Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysis.

Eur J Heart Fail · 2025 · PMC12103962 · PMID 39809551

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In 188 diabetic patients, SGLT2i had a highly significant overall anti‐inflammatory protective effect, reducing the risk of an increase in plasma inflammation biomarker levels by 47% ( Figure 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.